A detailed history of Slocum, Gordon & CO LLP transactions in Stryker Corp stock. As of the latest transaction made, Slocum, Gordon & CO LLP holds 17 shares of SYK stock, worth $6,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 74 77.03%
Holding current value
$6,098
Previous $25,000 76.0%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$315.94 - $371.96 $18,008 - $21,201
-57 Reduced 77.03%
17 $6,000
Q2 2023

Oct 23, 2023

BUY
$271.49 - $305.09 $20,090 - $22,576
74 New
74 $22,000
Q1 2023

Dec 14, 2023

SELL
$246.13 - $285.47 $14,029 - $16,271
-57 Reduced 77.03%
17 $4,000
Q4 2022

Dec 06, 2023

SELL
$205.51 - $253.93 $11,714 - $14,474
-57 Reduced 77.03%
17 $4.16 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.